A Population-Based Study on Congenital Disorders of Protein N- and Combined with O-Glycosylation Experience in Clinical and Genetic Diagnosis - 18/04/17
, Ma Luisa Girós, PhD 2, Mercedes Serrano, MD, PhD 3, 4, M. Jesús Ecay, BSc 1, Laura Gort, PhD 2, Belén Pérez Dueñas, MD, PhD 3, 4, Celia Medrano, PhD 1, Alfredo García-Alix, MD, PhD 5, Rafael Artuch, MD, PhD 3, 4, Paz Briones, PhD 2, Belén Pérez, PhD 1Abstract |
Objective |
To describe the clinical, biochemical, and genetic features of patients with congenital disorders of glycosylation (CDG) identified in Spain during the last 20 years.
Study design |
Patients were selected among those presenting with multisystem disease of unknown etiology. The isoforms of transferrin and of ApoC3 and dolichols were analyzed in serum; phosphomannomutase and mannosephosphate isomerase activities were measured in fibroblasts. Conventional or massive parallel sequencing (customized panel or Illumina Clinical-Exome Sequencing TruSight One Gene Panel) was used to identify genes and mutations.
Results |
Ninety-seven patients were diagnosed with 18 different CDG. Eighty-nine patients had a type 1 transferrin profile; 8 patients had a type 2 transferrin profile, with 6 of them showing an alteration in the ApoC3 isoform profile. A total of 75% of the patients had PMM2-CDG presenting with a heterogeneous mutational spectrum. The remaining patients showed mutations in any of the following genes: MPI, PGM1, GFPT1, SRD5A3, DOLK, DPGAT1, ALG1, ALG6, RFT1, SSR4, B4GALT1, DPM1, COG6, COG7, COG8, ATP6V0A2, and CCDC115.
Conclusion |
Based on literature and on this population-based study of CDG, a comprehensive scheme including reported clinical signs of CDG is offered, which will hopefully reduce the timeframe from clinical suspicion to genetic confirmation. The different defects of CDG identified in Spain have contributed to expand the knowledge of CDG worldwide. A predominance of PMM2 deficiency was detected, with 5 novel PMM2 mutations being described.
Le texte complet de cet article est disponible en PDF.Keywords : rare diseases, CDG phenotypes, PMM2-CDG, mutation, gene
Abbreviations : ApoC3, CDG, %CDT, ER, MPI, PMM2, Tf
Plan
| Funded by the National Plan for I+D+I, financed by the General sub-directorate of Evaluation and Promotion of Health Research and the European Regional Development Fund (PI14/00021, PI11/01096, PI11/01254, PI07/0118, PI04/0791), and the Ministry of Economy, Industry and Competitiveness (IPT-2012-0561-010000). The authors declare no conflicts of interest. |
Vol 183
P. 170 - avril 2017 Retour au numéro
Article précédent
- National Trends in Hemoglobin Concentration and Prevalence of Anemia among Chinese School-Aged Children, 1995-2010
- Yi Song, Hai-Jun Wang, Bin Dong, Zhiqiang Wang, Jun Ma, Anette Agardh
- Health-Related Quality of Life and Lifestyle Behavior Clusters in School-Aged Children from 12 Countries
- Dorothea Dumuid, Timothy Olds, Lucy K. Lewis, Josep Antoni Martin-Fernández, Peter T. Katzmarzyk, Tiago Barreira, Stephanie T. Broyles, Jean-Philippe Chaput, Mikael Fogelholm, Gang Hu, Rebecca Kuriyan, Anura Kurpad, Estelle V. Lambert, José Maia, Victor Matsudo, Vincent O. Onywera, Olga L. Sarmiento, Martyn Standage, Mark S. Tremblay, Catrine Tudor-Locke, Pei Zhao, Fiona Gillison, Carol Maher, International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE) research group *
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?